About MEDICEPTION SCIENCE PRIVATE LIMITED
MEDICEPTION SCIENCE PRIVATE LIMITED is a Private Limited Company and was incorporated on Jan 12, 2015 in India. It is registered at Registrar of Companies, ROC Delhi. Its registered address is 817, 8TH FLOOR, VIPUL BUSINESS PARK, VIPUL WORLD, SECTOR-48, SOHNA ROAD, GURUGRAM, Gurgaon, Gurgaon, Gurgaon, Haryana, India, 122018. Its corporate identification number is (CIN) U74900HR2015PTC054233 and its current status is Active. Its industry classification as per MCA is business Activities N.E.C.
MEDICEPTION SCIENCE PRIVATE LIMITED's last Annual General Meeting (AGM) was held on Sep 30, 2024 as per records from Ministry of Corporate Affairs (MCA). MEDICEPTION SCIENCE PRIVATE LIMITED's authorised share capital is ₹1L and its paid up capital is ₹1L. The current board of directors of MEDICEPTION SCIENCE PRIVATE LIMITED comprises Bhawana Srivastava and Punit kumar Srivastava.
MEDICEPTION SCIENCE PRIVATE LIMITED generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2025.
Key Metrics
CIN
U74900HR2015PTC054233
Location
Current Status
Active
Entity Type
Private Limited Company
Date Of Incorporation
Jan 12, 2015
Company Age
11 Years 8 Months
Registrar of Companies
ROC - Delhi
Last AGM Date
Sep 30, 2024
Latest Revenue
0 - ₹10 Cr as on Mar 31, 2025
Authorized Capital
₹1L
Paid Up Capital
₹1L
Contact Details for MEDICEPTION SCIENCE PRIVATE LIMITED
- *****@mediception.com, *****@gmail.com
- Registered Address
- 817, 8TH FLOOR, VIPUL BUSINESS PARK, VIPUL WORLD, SECTOR-48, SOHNA ROAD, GURUGRAM, Gurgaon, Gurgaon, Gurgaon, Haryana, India, 122018
Brands associated with MEDICEPTION SCIENCE PRIVATE LIMITED
There is one brand associated with MEDICEPTION SCIENCE PRIVATE LIMITED which include MediCeption .
Name | Short Description | Founded Year | Location | Current Stage |
|---|---|---|---|---|
Provider of medical writing, clinical trial support, market research and HEOR and training services | 2015 | Unfunded |
Principal Business Activity of MEDICEPTION SCIENCE PRIVATE LIMITED
The majority of MEDICEPTION SCIENCE PRIVATE LIMITED's turnover comes from Professional, scientific and technical activities.
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
M | Professional, scientific and technical activities | 72 | Scientific research and development | jib |
Auditor Details of MEDICEPTION SCIENCE PRIVATE LIMITED
Here is the list of auditors of MEDICEPTION SCIENCE PRIVATE LIMITED:
Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
AGARWAL MANISH & ASSOCIATES | cw{faap | {hoyeur | eskaluu |
Documents of MEDICEPTION SCIENCE PRIVATE LIMITEDFY 25 Available15 mins
15 minsFiling Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | - | ||||
Annual Returns |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
Form AOC-4 | Annual Returns and Balance Sheet eForms | Dec 26, 2025 |
e-Director’s Report | Annual Returns and Balance Sheet eForms | Dec 26, 2025 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Dec 26, 2025 |
Optional attachment(s) - if any | Annual Returns and Balance Sheet eForms | Dec 26, 2025 |
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents) | Annual Returns and Balance Sheet eForms | Dec 26, 2025 |
List of share holders, debenture holders | Annual Returns and Balance Sheet eForms | Dec 25, 2025 |
Form MGT-7A | Annual Returns and Balance Sheet eForms | Dec 25, 2025 |
Photograph of the registered office of the Company showing external building and name prominently visible | Annual Returns and Balance Sheet eForms | Dec 25, 2025 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Dec 25, 2025 |
Form INC-22 | Other eForm Documents | Aug 25, 2025 |
To access all company documents and filings with a single purchase, Buy Financials and Company Filings FY 25 Available15 mins
Financials of MEDICEPTION SCIENCE PRIVATE LIMITEDFY 25 Available15 mins
MEDICEPTION SCIENCE PRIVATE LIMITED generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of MEDICEPTION SCIENCE PRIVATE LIMITED has a compounded annual growth rate (CAGR) of 42% in the last 1 year.
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 5929 | 8037 | 7113 | 7594 | 2066 |
Total Sales | 1926 | 2839 | 6718 | 4792 | 6223 |
Total Expenses | 6618 | 2847 | 6179 | 4582 | 4023 |
Operating Expenses | 5923 | 6094 | 5051 | 8277 | 4478 |
Employee Expenses | 1404 | 9299 | 7033 | 6138 | 4886 |
Operating Income (EBIT) | 7201 | 8165 | 5781 | 5839 | 8531 |
Interest Expenses | 1508 | 8062 | 9183 | 3101 | 6463 |
Expenses from other activities | 6507 | 3879 | 5128 | 3707 | 1930 |
EBITDA | 4439 | 3550 | 1537 | 5195 | 5064 |
Taxes | 2465 | 5124 | 8403 | 7457 | 2515 |
Net Profit | 8194 | 1002 | 4449 | 5995 | 8900 |
Balance Sheet | |||||
Assets | 1981 | 9769 | 1250 | 4437 | 5319 |
Accounts Receivables | 2613 | 4601 | 5323 | 1085 | 2046 |
Inventory | 7085 | 3465 | 4722 | 5915 | 4168 |
Liabilities | 7042 | 7403 | 2156 | 3973 | 5808 |
Total Debt | 9445 | 1538 | 9163 | 6863 | 4292 |
Accounts Payable | 9033 | 8027 | 1819 | 4117 | 2852 |
Equities | 2778 | 7218 | 3291 | 5853 | 4541 |
To access detailed financial performance and data, Buy Financial Report FY 25 Available15 mins
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 7137 | 4268 | 2891 | 7826 | 9837 |
EBIT Margin | 1255 | 6262 | 3440 | 8118 | 6389 |
Net Profit Margin | 6309 | 5203 | 4589 | 6028 | 3604 |
Return on Assets (ROA) | 2392 | 7756 | 9597 | 5908 | 6698 |
Return on Equity (ROE) | 8195 | 1994 | 1193 | 5912 | 4729 |
Return on Capital Employed | 3219 | 9979 | 3912 | 2394 | 9040 |
Return on Invested Capital | 7994 | 9581 | 1215 | 3903 | 8421 |
Efficiency Ratios | |||||
Asset Turnover | 5733 | 5152 | 8171 | 5614 | 5324 |
Receivables Turnover | 2641 | 9463 | 4898 | 6523 | 3482 |
Days Sales Outstanding | 8173 | 3683 | 8679 | 8350 | 2467 |
Inventory Turnover | 4566 | 6330 | 7570 | 5874 | 8915 |
Days Inventory Outstanding | 3215 | 1084 | 8948 | 2133 | 8839 |
Payables Turnover | 4781 | 3685 | 9824 | 7412 | 5342 |
Days Payables Outstanding | 2302 | 3505 | 8356 | 9329 | 8592 |
Liquidity Ratios | |||||
Current Ratio | 3588 | 9794 | 2381 | 8554 | 4330 |
Quick Ratio | 1482 | 4169 | 8100 | 7324 | 9890 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 7330 | 7328 | 4602 | 4381 | 1952 |
Debt Ratio | 4555 | 9600 | 1273 | 6461 | 6876 |
Interest Coverage Ratio | 7381 | 4707 | 3204 | 2973 | 6142 |
Debt Service Coverage Ratio | 4830 | 2259 | 6012 | 2179 | 8783 |
Net Debt/EBITDA | 2888 | 9022 | 7525 | 1784 | 2418 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 2092 | 8655 | 3890 | 8311 | 7533 |
Earnings Growth Rate (CAGR) | 4815 | 8298 | 7571 | 1940 | 2267 |
To access detailed financial performance and data, Buy Financial Report FY 25 Available15 mins
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of MEDICEPTION SCIENCE PRIVATE LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | 42% |
3 Year | 431 |
5 Year | 663 |
EBITDA CAGR | Growth |
|---|---|
1 Year | 190% |
3 Year | 119 |
5 Year | 553 |
MSME Payment Delays by MEDICEPTION SCIENCE PRIVATE LIMITED
GSTIN Details of MEDICEPTION SCIENCE PRIVATE LIMITED
Board of Directors and Signatories of MEDICEPTION SCIENCE PRIVATE LIMITED
Board of Directors of MEDICEPTION SCIENCE PRIVATE LIMITED
Here is the list of current board of directors of MEDICEPTION SCIENCE PRIVATE LIMITED:
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Jan 12, 2015 | 11 Years 8 Months | |
Director | Current | Sep 30, 2018 | 8 Years |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Signatories of MEDICEPTION SCIENCE PRIVATE LIMITED
Here is the list of current signatories of MEDICEPTION SCIENCE PRIVATE LIMITED:
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Jan 12, 2015 | 11 Years 8 Months | |
Director | Current | Sep 30, 2018 | 8 Years |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Cross Directorships of MEDICEPTION SCIENCE PRIVATE LIMITED
MEDICEPTION SCIENCE PRIVATE LIMITED has directors who also hold positions in 2 other legal entities. All are listed below:
Legal Entity Name | % of Common Directors | Common Director(s) | Open Charge(s) | Active Legal Case(s) |
|---|---|---|---|---|
KEMFICON PRIVATE LIMITED CIN: U73100HR2020PTC086155, India, Active | 843 | 213 | 933 | 890 |
MEDVALEN LIFE SCIENCE PRIVATE LIMITED CIN: U85100DL2012PTC232822, India, Strike off | 640 | 443 | 494 | 912 |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Legal Cases involving MEDICEPTION SCIENCE PRIVATE LIMITED
Competitors & Alternates of MEDICEPTION SCIENCE PRIVATE LIMITED
MediCeption is the only brand associated with MEDICEPTION SCIENCE PRIVATE LIMITED, and here are its Top 10 competitors ranked by Tracxn score:
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Indegene 1998, Princeton (United States), Public | Suite solutions for payers and healthcare providers | $255M | 78/100 | |
2nd | IntegriChain 2005, Philadelphia (United States), Acquired | Pharma commercialization solutions: data, consulting, and technology for market access | $2M | 63/100 | |
3rd |  Prescient Healthcare Group 2007, London (United Kingdom), Series B | Consulting services for product strategy and decision support | $12.7M | 60/100 | |
4th |  Clinigen 2010, Burton-on-trent (United Kingdom), Acquired | Services in clinical trials & medicine supply | - | 59/100 | |
5th | CMIC HOLDINGS 1985, Tokyo (Japan), Acquired | Contract service provider for biopharma companies | - | - | 58/100 |
6th |  Fishawack 2001, Brighton (United Kingdom), Acquired | Provider of fully-integrated, cross-border services to global pharmaceutical organisations | $23.6M | - | 57/100 |
7th | Provider of instruments for biotech, pharmaceutical, and biomedical industries | $175K | 56/100 | ||
8th | Diaceutics 2005, Belfast (United Kingdom), Public | Analytics based integrator for precision medicine | - | 55/100 | |
9th |  Spectrum Pharmatech Consultants 1995, Thane (India), Unfunded | Provider of diversified consulting services for biopharma sector | - | - | 49/100 |
10th |  Sequence 2002, Morrisville (United States), Acquired | Consulting services provider | - | - | 49/100 |
124th |  MediCeption 2015, Gurugram (India), Unfunded | Provider of medical writing, clinical trial support, market research and HEOR and training services | - | - | 29/100 |
To view the full list of competitors of MediCeption, Buy Detailed Report
FAQs about MEDICEPTION SCIENCE PRIVATE LIMITED
Explore our recently published Legal Entities
